Shiota G - Search Results

1

Prognostic relevance of miR-137 in patients with hepatocellular carcinoma.

Sakabe T, Azumi J, Umekita Y, Toriguchi K, Hatano E, Hirooka Y, Shiota G. Sakabe T, et al. Among authors: shiota g. Liver Int. 2017 Feb;37(2):271-279. doi: 10.1111/liv.13213. Epub 2016 Aug 16. Liver Int. 2017. PMID: 27473646

2

Frequent loss in chromosome 8p loci in liver cirrhosis accompanying hepatocellular carcinoma.

Kishimoto Y, Shiota G, Wada K, Kitano M, Nakamoto K, Kamisaki Y, Suou T, Itoh T, Kawasaki H. Kishimoto Y, et al. Among authors: shiota g. J Cancer Res Clin Oncol. 1996;122(10):585-9. doi: 10.1007/BF01221189. J Cancer Res Clin Oncol. 1996. PMID: 8879255

3

Loss of the tumor suppressor p53 gene at the liver cirrhosis stage in Japanese patients with hepatocellular carcinoma.

Kishimoto Y, Shiota G, Kamisaki Y, Wada K, Nakamoto K, Yamawaki M, Kotani M, Itoh T, Kawasaki H. Kishimoto Y, et al. Among authors: shiota g. Oncology. 1997 Jul-Aug;54(4):304-10. doi: 10.1159/000227708. Oncology. 1997. PMID: 9216855

4

Loss of heterozygosity of the retinoblastoma gene in liver cirrhosis accompanying hepatocellular carcinoma.

Ashida K, Kishimoto Y, Nakamoto K, Wada K, Shiota G, Hirooka Y, Kamisaki Y, Itoh T, Kawasaki H. Ashida K, et al. Among authors: shiota g. J Cancer Res Clin Oncol. 1997;123(9):489-95. doi: 10.1007/BF01192203. J Cancer Res Clin Oncol. 1997. PMID: 9341898

5

Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.

Shiota G, Kishimoto Y, Suyama A, Okubo M, Katayama S, Harada K, Ishida M, Hori K, Suou T, Kawasaki H. Shiota G, et al. J Hepatol. 1997 Oct;27(4):661-8. doi: 10.1016/s0168-8278(97)80083-9. J Hepatol. 1997. PMID: 9365042 Clinical Trial.

6

Expression of hepatocyte growth factor (HGF) and HGF receptor (c-met) proteins in liver diseases: an immunohistochemical study.

Okano J, Shiota G, Kawasaki H. Okano J, et al. Among authors: shiota g. Liver. 1999 Apr;19(2):151-9. doi: 10.1111/j.1478-3231.1999.tb00025.x. Liver. 1999. PMID: 10220746

7

Cyclooxygenase-2 expression in hepatocellular carcinoma.

Shiota G, Okubo M, Noumi T, Noguchi N, Oyama K, Takano Y, Yashima K, Kishimoto Y, Kawasaki H. Shiota G, et al. Hepatogastroenterology. 1999 Jan-Feb;46(25):407-12. Hepatogastroenterology. 1999. PMID: 10228831

8

Prognosis for pedunculated hepatocellular carcinoma.

Horie Y, Shigoku A, Tanaka H, Tomie Y, Maeda N, Hoshino U, Koda M, Shiota G, Yamamoto T, Kato S, Murawaki Y, Suou T, Kawasaki H. Horie Y, et al. Among authors: shiota g. Oncology. 1999 Jul;57(1):23-8. doi: 10.1159/000011996. Oncology. 1999. PMID: 10394121

9

Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma.

Harada K, Shiota G, Kawasaki H. Harada K, et al. Among authors: shiota g. Liver. 1999 Aug;19(4):318-25. doi: 10.1111/j.1478-3231.1999.tb00056.x. Liver. 1999. PMID: 10459631

10

Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53.

Shiota G, Oyama K, Udagawa A, Tanaka K, Nomi T, Kitamura A, Tsutsumi A, Noguchi N, Takano Y, Yashima K, Kishimoto Y, Suou T, Kawasaki H. Shiota G, et al. J Med Virol. 2000 Oct;62(2):151-8. doi: 10.1002/1096-9071(200010)62:2<151::aid-jmv5>3.0.co;2-n. J Med Virol. 2000. PMID: 11002243

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters